Manufacturer
Novo Nordisk
Official corporate and annual-report sources reviewed
Unclaimed profileReviewed Jul 10, 2026
Manufacturing profile
- Focus
- Diabetes, obesity, and other chronic-disease medicines
- Capabilities
- Pharmaceutical research, clinical development, and global commercial manufacturing
- Regulated products
- Includes semaglutide medicines such as Ozempic and Wegovy
- Scope
- Large-scale regulated pharmaceutical manufacturing and distribution
Editorial record
This manufacturer record distinguishes approved Novo Nordisk medicines from compounded products and research-use-only materials.
Profile ownership: unclaimed. Company representatives will be able to propose identity and catalog updates without changing editorial or regulatory records.